Results 91 to 100 of about 1,331 (171)

Recommendations for the management of tyrosinaemia type 1

open access: yesOrphanet Journal of Rare Diseases, 2013
The management of tyrosinaemia type 1 (HT1, fumarylacetoacetase deficiency) has been revolutionised by the introduction of nitisinone but dietary treatment remains essential and the management is not easy.
de Laet Corinne   +8 more
doaj   +1 more source

Alkaptonuria: Current Perspectives

open access: yesThe Application of Clinical Genetics, 2020
Andrea Zatkova,1 Lakshminarayan Ranganath,2 Ludevit Kadasi1,3 1Department of Human Genetics, Biomedical Research Center, Slovak Academy of Sciences, Institute of Clinical and Translational Research, Bratislava, Slovakia; 2National Alkaptonuria Centre ...
Zatkova A, Ranganath L, Kadasi L
doaj  

Anopheles mosquito survival and pharmacokinetic modeling show the mosquitocidal activity of nitisinone [PDF]

open access: yes
One approach to interrupting the transmission of insect-borne diseases that is successfully used in veterinary medicine is exploiting the ability of antiparasitic drugs to make vertebrate blood toxic for blood-feeding insects.
Burrows, Jeremy N.   +13 more
core   +1 more source

A Simple Isocratic RP-HPLC Method for Determination of Nitisinone in Pharmaceuticals [PDF]

open access: yes, 2019
Nitisinone is a reversible inhibitor of 4-hydroxyphenylpyruvate dioxygenase and an active substance in the orphan drug used for the treatment of hereditary tyrosinemia type I, a rare genetic disease caused by mutations in the gene for the enzyme ...
Mustafa, Zana   +3 more
core   +1 more source

Metabolomic changes associated with acquired resistance to Ixodes scapularis

open access: yesTicks and Tick-Borne Diseases
Guinea pigs repeatedly exposed to Ixodes scapularis develop acquired resistance to the ticks (ATR). The molecular mechanisms of ATR have not been fully elucidated, and partially involves immune responses to proteins in tick saliva.
Yingjun Cui   +6 more
doaj   +1 more source

Behavioral and intellectual functioning in patients with tyrosinemia type I [PDF]

open access: yesPediatric Endocrinology, Diabetes and Metabolism, 2012
Introduction: In tyrosinemia type I (TT1) increased level of tyrosine and phenylalanine (both precursors of neurotransmitters), may potentially influence patients’ cognitive development.
Agnieszka Kowalik   +6 more
doaj  

Nitisinone

open access: yesDrugs in R & D, 2002
openaire   +2 more sources

Response to comment on: Evaluating the impact of nitisinone at mosquito-lethal doses on Lutzomyia longipalpis. [PDF]

open access: yesPLoS Negl Trop Dis
Augendre L   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy